Neuromodulation Devices Market Scope And Analysis

  • Report Code : TIPRE00018069
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Neuromodulation Devices Market Analysis 2021 to 2031

Buy Now

Neuromodulation Devices Market Report Neuromodulation Devices Market Size and Share Neuromodulation Devices Market Scope and Analysis

Neuromodulation Devices Market Report Scope

Report Attribute Details
Market size in 2022 US$ 5.73 Billion
Market Size by 2030 US$ 11.61 Billion
Global CAGR (2022 - 2030) 9.2%
Historical Data 2020-2022
Forecast period 2022-2030
Segments Covered By Type
  • Internal
  • External
By Application
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation
  • Gastric Electrical Stimulation
  • Spinal Cord Stimulation
  • Vagus Nerve Stimulation
By Biomaterial
  • Metallic
  • Polymeric
  • Ceramic
By End User
  • Hospitals
  • Clinics
  • Home Healthcare
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott St Jude Medical Inc
  • LivaNova PLC
  • Boston Scientific Corporation
  • Aleva Neurotherapeutics SA
  • Bioventus
  • EnteroMedics Inc
  • Nevro Corporation
  • NeuroPace Inc
  • Synapse Biomedical Inc